Skip to content

Clinical Efficacy Evaluation of Xing-Shen coordination Interactive Acupuncture for Post-Stroke Spastic Hemiplegia

Clinical Efficacy Evaluation and Mechanism Study of Xing-Shen coordination Interactive Acupuncture for Post-Stroke Spastic Hemiplegia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001662
Enrollment
Unknown
Registered
2025-09-03
Start date
2025-05-30
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Stroke Spastic Hemiplegia

Interventions

Body-spirit coordinated interactive acupuncture group :Acupuncture was added to the conventional treatment
Sham-acupuncture group:Sham-acupuncture was added to the conventional treatment
Conventional treatment:Nerve nutrition, improved blood circulation, rehabilitation training, etc

Sponsors

Dongzhimen Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meeting diagnostic criteria for stroke confirmed by cranial CT or MRI; (2) First-ever stroke or recurrent stroke without residual neurological deficits; (3) Disease course: 2 weeks to 6 months post-onset; (4) Age 35-75 years any gender; (5) Presence of hemiplegia or monoplegia with increased muscle tone Modified Ashworth Scale (MAS) grade 1-3; (6) Neurological deficit severity: NIHSS score 4-16; (7) Conscious (GCS score=15) clinically stable and capable of cooperating with interviews physical examinations instructions and treatment; (8) Voluntary participation with signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Severe primary diseases of cardiovascular hepatic renal immune or hematopoietic systems; infectious diseases malignancies or psychiatric disorders; coagulation dysfunction; (2) Secondary epilepsy or history of craniocerebral/spinal trauma or surgery; (3) Motor dysfunction (e.g. rheumatoid arthritis fractures trauma) that may interfere with efficacy evaluation; (4) Use of muscle relaxants within 1 month or receipt of acupuncture therapy within 3 months; (5) Skin lesions inflammation or scars at acupoints; allergy to trial materials (alcohol acupuncture needles) or severe allergic predisposition; (6) Positive pregnancy test current pregnancy/lactation or pregnancy planning within trial period; (7) Participation in other acupuncture/drug clinical trials within 3 months prior to screening or current enrollment.

Design outcomes

Primary

MeasureTime frame
Modified Ashworth Scale (MAS) ;

Secondary

MeasureTime frame
Maximum Elasticity Modulus (Emax) in shear wave elastography;National Institutes of Health Stroke Scale (NIHSS);Clinical Spasticity Index (CSI);Fugl-Meyer Assessment (FMA) ;Surface Electromyography (sEMG);Barthel Index (BI);

Countries

China

Contacts

Public ContactJinxia-ni

Dongzhimen Hospital Beijing University of Chinese Medicine

nijinxia118@126.com15210816781

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 6, 2026